CXCR4 and COVID-19: It is also interesting to note that in the transcriptomic studies, the significantly reduced expression of the MIF co-receptor CXCR4 paralleled that of CD74, suggesting that a common mechanism of downregulated expression could occur during moderate and severe cases of COVID-19.